Boji Medical Technology Co.,Ltd. (SHE:300404)
12.10
+0.21 (1.77%)
Nov 5, 2026, 4:00 PM EST
Boji Medical Technology Revenue
Boji Medical Technology had revenue of 277.65M CNY in the quarter ending September 30, 2026, with 24.58% growth. This brings the company's total for the last twelve months to 1.02B, up 31.93% year-over-year. In the year 2025, Boji Medical Technology had annual revenue of 868.64M with 17.06% growth. That makes Boji Medical Technology the 19,512th largest company in the world by revenue and 3,569th in China.
Revenue (ttm)
1.02B
Revenue Growth
+31.93%
P/S Ratio
4.56
Revenue / Employee
848.18K
Employees
1,198
Market Cap
4.64B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Boji Medical Technology breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 868.64M | 126.62M | 17.06% |
| Dec 31, 2024 | 742.02M | 186.19M | 33.50% |
| Dec 31, 2023 | 555.83M | 132.15M | 31.19% |
| Jan 1, 2023 | 423.68M | 99.48M | 30.68% |
| Jan 1, 2022 | 324.20M | 63.73M | 24.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Anhui Huaheng Biotechnology | 3.04B |
| Youcare Pharmaceutical Group | 2.36B |
| ChemPartner PharmaTech | 1.27B |
| Shenzhen Weiguang Biological Products | 1.13B |
| R&G PharmaStudies | 957.42M |
| Beijing Konruns Pharmaceutical | 863.12M |
| Wuhan Keqian Biology Co.,Ltd | 786.77M |
| Jiangsu Aidea Pharmaceutical Group | 716.78M |